The agreement gives Virax immediate purchase-order-based access to Thailand, Vietnam, Indonesia, the Philippines, Singapore and Malaysia, while separating near-term commercial activity from its in-development ViraxImmune platform.
verifying reliability
No specialized terms available for this topic.